As of July 17, 2025, Healios KK (4593.T) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Healios KK's Forward P/E to Peers
To better understand Healios KK's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Healios KK (4593.T) | - |
| ABL Bio Inc (298380.KQ) | 117.39 |
| Takara Bio Inc (4974.T) | 25.48 |
| Yantai Zhenghai Bio-Tech Co Ltd (300653.SZ) | 24.60 |
| GNI Group Ltd (2160.T) | 15.97 |
| PeptiDream Inc (4587.T) | 13.69 |
Compared to its competitors, Healios KK's Forward P/E is difficult to compare due to insufficient data.